ATE317275T1 - Blindungsvorrichtung für klinische prüfungen - Google Patents

Blindungsvorrichtung für klinische prüfungen

Info

Publication number
ATE317275T1
ATE317275T1 AT99971721T AT99971721T ATE317275T1 AT E317275 T1 ATE317275 T1 AT E317275T1 AT 99971721 T AT99971721 T AT 99971721T AT 99971721 T AT99971721 T AT 99971721T AT E317275 T1 ATE317275 T1 AT E317275T1
Authority
AT
Austria
Prior art keywords
clinical trials
blinding device
blinding
pharmaceutical
intended
Prior art date
Application number
AT99971721T
Other languages
German (de)
English (en)
Inventor
Peter Schaffer
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE317275T1 publication Critical patent/ATE317275T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Bag Frames (AREA)
  • Packages (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT99971721T 1998-11-06 1999-11-05 Blindungsvorrichtung für klinische prüfungen ATE317275T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19851119A DE19851119C2 (de) 1998-11-06 1998-11-06 Behälter und Vorrichtung zur Blindung der Verabreichung von nicht festen pharmazeutischen Darreichungsformen bei der klinischen Prüfung

Publications (1)

Publication Number Publication Date
ATE317275T1 true ATE317275T1 (de) 2006-02-15

Family

ID=7886853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99971721T ATE317275T1 (de) 1998-11-06 1999-11-05 Blindungsvorrichtung für klinische prüfungen

Country Status (9)

Country Link
US (1) US6544250B1 (enExample)
EP (1) EP1126888B1 (enExample)
JP (1) JP2002529151A (enExample)
AT (1) ATE317275T1 (enExample)
AU (1) AU1380100A (enExample)
CA (1) CA2350644C (enExample)
DE (2) DE19851119C2 (enExample)
ES (1) ES2258350T3 (enExample)
WO (1) WO2000027448A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH696069A5 (de) * 2002-12-19 2006-12-15 Fisher Clinical Services Ag Behälter und dessen Verwendung in einer Verpackung, beispielsweise Heilmittelverpackung.
DE202004007115U1 (de) * 2004-05-03 2004-07-08 Altana Pharma Ag Blindungsvorrichtung
WO2011011035A2 (en) * 2009-07-24 2011-01-27 Millipore Corporation Feed bag construction
JP2015506743A (ja) * 2012-01-16 2015-03-05 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 治験用の盲検キット
EP2804643B1 (en) * 2012-01-16 2017-12-06 Sanofi-Aventis Deutschland GmbH Blinding kit for clinical trials

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE255260C (enExample)
DD255260A (enExample) *
US3572340A (en) * 1968-01-11 1971-03-23 Kendall & Co Suction drainage device
CH573026A5 (enExample) * 1974-06-11 1976-02-27 Kaiser Josef Ag Fahrzeugwerk
CA1265963A (en) * 1984-03-02 1990-02-20 George Joseph Duffy Injection device
IT221762Z2 (it) * 1991-03-25 1994-10-20 Salvatore Sapienza Siringa opaca
KR100269731B1 (ko) * 1993-07-15 2000-10-16 하루타 히로시 영상 프로세서용 광원장치
IT1260685B (it) * 1993-09-29 1996-04-22 Sorin Biomedica Spa Dispositivo per il contenimento di sangue
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US5658248A (en) * 1995-08-04 1997-08-19 Localmed, Inc. Double-blind infusion device and method
US5980834A (en) * 1996-07-25 1999-11-09 The United States Of America As Represented By The Secretary Of Commerce Sample storage devices
US6287284B1 (en) * 1999-09-27 2001-09-11 Npt, Inc. Silicone bag assembly
US6569122B2 (en) * 2001-01-18 2003-05-27 Ultradent Products, Inc Syringe apparatus for delivering light activated materials

Also Published As

Publication number Publication date
DE59913117D1 (de) 2006-04-20
JP2002529151A (ja) 2002-09-10
ES2258350T3 (es) 2006-08-16
CA2350644A1 (en) 2000-05-18
US6544250B1 (en) 2003-04-08
EP1126888B1 (de) 2006-02-08
AU1380100A (en) 2000-05-29
DE19851119A1 (de) 2000-05-18
DE19851119C2 (de) 2001-05-31
EP1126888A1 (de) 2001-08-29
CA2350644C (en) 2008-04-01
WO2000027448A1 (de) 2000-05-18

Similar Documents

Publication Publication Date Title
ES2129806T3 (es) Composiciones liquidas orales que contienen resinato de paroxetina.
DE3870691D1 (de) Spender fuer viskose fluessigkeiten.
AR031162A1 (es) Surtidor de medicamento y su uso
DE68908815D1 (de) Aufgeber für Arzneimittel.
BR9711121A (pt) Mamadeira aperfeiçoada
ID28003A (id) Turunan-turunan adamantana
DE69004098D1 (de) Medizinisches spendesystem für gewebeklebstoffkomponenten.
DE69625408D1 (de) Doppelfluidabgabeeinrichtung für Wirkstoffflüssigkeiten
DZ2686A1 (fr) Formulation pharmaceutique orale à libération pulsée.
NO20015816L (no) Indanylsubstituerte benzenkarbonamider, fremgangsmåter for fremstilling derav, anvendelse derav som medikament ogfarmasöytiske preparater inneholdende disse
CY1109997T1 (el) Περιεκτης και μεθοδος χορηγησης διαδερμικων δοσολογικων μορφων
DE60025482D1 (de) Spritzgegossener stopfen für arzneimittelbehälter
CL2007001889A1 (es) Uso de un inhibidor de proteina farnesil tansferasa (fpt) definido, que es una benzocicloheptapiridina, en combinacion con paclitaxel para preparar un medicamento util para tratar una enfermedad proliferativa en un paciente
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
ATE317275T1 (de) Blindungsvorrichtung für klinische prüfungen
NO20001415L (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.
AR013559A1 (es) USO DE DERIVADOS DE PIRROLIDINA PARA LA PREPARACIoN DE MEDICAMENNTOS DESTINADOS AL TRATAMIENTO DEL ABUSO DE DROGAS O DE SUSTANCIAS QUE DAN ORIGEN A LA ADICCIoN O AL USO EXCESIVO DE DROGAS , CON EXCEPCIoN DEL ABUSO DEL ALCOHOL, MEDIANTE LA REDUCCIoN DE LA AUTO-MEDICACIoN DE DICHAS DROGAS POR PARTE DE
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
GB9811221D0 (en) Bacterial-pheromones and uses therefor
FI890348L (fi) Silloittuvien paineherkkien liimojen välituotekoostumukset, jotka sisältävät nestemäistä kopolymeeristä organopolysiloksaania
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
AU2001258638A1 (en) Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner